In the future it will be common practice to use stem cell products to treat illnesses in the same way we use medications today

Pipeline

ADSC for the treatment of Multiple Sclerosis (MS)
- Clinical trial: A Prospective, Single Center, Open Label, Dose Escalation Phase I/IIa Study to Assess the Safety and Efficacy of an Intrathecal Administration of SCM-010 in Subjects With Secondary Progressive Multiple Sclerosis (SPMS)
Anti-BMP small molecules for the treatment of MS
Genetically modified muscle progenitor cells (MPCs) that secrete neurotropic factors (NTFs)
- MPC-NTFs: peripheral nerve injury
- MPC-NTFs: neuropathic pain
Mesenchymal stem cell derived vesicles – exosomes secreted from cells for the treatment of autistic disorders
Production and Supply of Finolim (Fingolimod, Gilenia™)
Adipose-derived stem cell (ADSC) secreted factors: cosmetic products